journal article·2025-01Open access

Selenized Tripterine Phytosomes Alleviate Ferroptosis-Mediated Acute Kidney Injury by Suppressing GPX4 Degradation via the DUSP1/Autophagy Pathway

Liang Yan, Qi Feng, Yong Sun, Bo-ning Zeng, Chuan-chuan Sun, Qing-bing Zha, Xing-wang Zhang, Shi-ping Zhu

Abstract

Ferroptosis, a form of lipid peroxidation-mediated cell death, plays a critical role in acute kidney injury (AKI) progression. Tripterine is an active component isolated from traditional medicinal herbs and exhibits diverse biological and pharmacological activities. However, poor bioavailability and cytotoxicity of tripterine has limited its further clinical application, and the underlying action mechanism of tripterine against AKI remains largely unknown. This study aimed to overcome these shortcomings by formulating tripterine into selenized phytosomes and to investigate the therapeutic effects of selenized tripterine phytosomes (Se@Tri-PTs) on ferroptosis-associated AKI. The data showed that Se@Tri-PTs improved the antioxidant capacity of tripterine while reducing its cytotoxicity. Upon erastin or RSL3 stimulation, Se@Tri-PTs maintained intracellular glutathione levels, decreased lipid ROS generation, and suppressed ferroptosis. Mechanistically, Se@Tri-PTs blocked autophagy-mediated degradation of glutathione peroxidase 4 (GPX4), thereby suppressing ferroptosis. Furthermore, Se@Tri-PTs maintained dual-specificity protein phosphatase 1 (DUSP1) protein levels in erastin-stimulated cells, and DUSP1 knockdown reversed Se@Tri-PTs-mediated inhibition of autophagy and ferroptosis. In line with in vitro results, Se@Tri-PTs administration obviously attenuated folic acid-induced AKI and autophagy-dependent ferroptosis in mice. Collectively, these results indicated that Se@Tri-PTs ameliorated ferroptosis and AKI by preserving DUSP1 levels to block autophagy-mediated degradation of GPX4, highlighting their potential in treating ferroptosis-related diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ferroptosis and cancer prognosis · Iron Metabolism and Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangdong Provincial Key Laboratory of Spine and Spinal Cord Reconstruction, The Fifth Affiliated Hospital (Heyuan Shenhe People’s Hospital), Jinan University, Heyuan 517000, China.

Department of Chinese Traditional Medicine, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.

Department of Clinical Laboratory, The Fifth Affiliated Hospital (Heyuan Shenhe People’s Hospital), Jinan University, Heyuan 517000, China.

Department of Medical Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou 510632, China.

School of Medicine, Jinan University, Guangzhou 510630, China.

Department of General Practice, The 3rd Affiliated Hospital of Shenzhen University (Shenzhen Luohu People’s Hospital), Shenzhen 518001, China.

Department of Nephrology, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.

Department of Pharmaceutics, School of Pharmacy, Jinan University, Guangzhou 511443, China.

Funding

the National Natural Science Foundation of China · Basic and Applied Basic Research Project of Guangzhou Science and Technology Plan · the Science and Technology Project of Heyuan, China Social Development and Rural Science · the Project of Guangdong Administration of Traditional Chinese Medicine · Guangzhou Science and Technology Program · China Postdoctoral Science Foundation

References (49)

Show source-provided references
1. 10.1016/S0140-6736(24)02385-710.1016/S0140-6736(24)02385-7 ↗
2. 10.1016/j.kint.2023.03.02510.1016/j.kint.2023.03.025 ↗
3. 10.1038/s41419-022-04628-910.1038/s41419-022-04628-9 ↗
4. 10.1038/s41422-020-00441-110.1038/s41422-020-00441-1 ↗
5. 10.3389/fmed.2022.107186410.3389/fmed.2022.1071864 ↗
6. 10.1080/15548627.2023.216532310.1080/15548627.2023.2165323 ↗
7. 10.1038/s41419-021-04306-210.1038/s41419-021-04306-2 ↗
8. 10.1038/ncb306410.1038/ncb3064 ↗
9. 10.1038/s41419-020-03362-410.1038/s41419-020-03362-4 ↗
10. 10.1016/j.phrs.2021.10557210.1016/j.phrs.2021.105572 ↗
11. 10.1016/j.ejmech.2020.11208110.1016/j.ejmech.2020.112081 ↗
12. 10.1016/j.freeradbiomed.2021.06.02010.1016/j.freeradbiomed.2021.06.020 ↗
13. 10.2174/156652401966619042413170410.2174/1566524019666190424131704 ↗
14. 10.1016/j.biopha.2023.11533310.1016/j.biopha.2023.115333 ↗
15. 10.1016/j.ijpharm.2015.10.01110.1016/j.ijpharm.2015.10.011 ↗
16. 10.1038/cddis.2014.54310.1038/cddis.2014.543 ↗
17. 10.1016/j.ijpharm.2020.11910410.1016/j.ijpharm.2020.119104 ↗
18. 10.1016/j.intimp.2022.10887110.1016/j.intimp.2022.108871 ↗
19. 10.2174/011381612827507923110207150810.2174/0113816128275079231102071508 ↗
20. 10.3389/fimmu.2017.0140910.3389/fimmu.2017.01409 ↗
21. 10.3389/fphar.2021.67008110.3389/fphar.2021.670081 ↗
22. 10.1111/bph.1536410.1111/bph.15364 ↗
23. 10.1016/j.apsb.2021.02.02110.1016/j.apsb.2021.02.021 ↗
24. 10.1016/j.cell.2013.12.01010.1016/j.cell.2013.12.010 ↗
25. 10.1038/s41420-022-01212-010.1038/s41420-022-01212-0 ↗
26. 10.1016/j.freeradbiomed.2018.09.01410.1016/j.freeradbiomed.2018.09.014 ↗
27. 10.1016/j.molcel.2020.10.01010.1016/j.molcel.2020.10.010 ↗
28. 10.1073/pnas.181972811610.1073/pnas.1819728116 ↗
29. 10.1016/j.gene.2021.14599210.1016/j.gene.2021.145992 ↗
30. 10.1016/j.chembiol.2020.03.01610.1016/j.chembiol.2020.03.016 ↗
31. 10.1080/15548627.2022.205917010.1080/15548627.2022.2059170 ↗
32. 10.1186/s12964-024-01751-210.1186/s12964-024-01751-2 ↗
33. 10.1016/j.cell.2019.03.03210.1016/j.cell.2019.03.032 ↗
34. 10.3945/an.110.00026510.3945/an.110.000265 ↗
35. 10.1016/j.bulcan.2020.11.00410.1016/j.bulcan.2020.11.004 ↗
36. 10.1016/j.apsb.2021.07.02110.1016/j.apsb.2021.07.021 ↗
37. 10.1080/15548627.2016.120348310.1080/15548627.2016.1203483 ↗
38. 10.1016/j.redox.2017.11.00410.1016/j.redox.2017.11.004 ↗
39. 10.1097/JP9.000000000000005410.1097/JP9.0000000000000054 ↗
40. 10.1002/path.588210.1002/path.5882 ↗
41. 10.1016/j.redox.2022.10226210.1016/j.redox.2022.102262 ↗
42. 10.1016/j.jtcvs.2018.06.09110.1016/j.jtcvs.2018.06.091 ↗
43. 10.1073/pnas.141551811110.1073/pnas.1415518111 ↗
44. 10.1681/ASN.201512137610.1681/ASN.2015121376 ↗
45. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
46. 10.1016/j.tips.2023.08.01210.1016/j.tips.2023.08.012 ↗
47. 10.1016/j.jare.2020.07.00710.1016/j.jare.2020.07.007 ↗
48. 10.1039/D0TB01939A10.1039/D0TB01939A ↗
49. 10.3389/fphar.2021.67320910.3389/fphar.2021.673209 ↗